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Objective: Because presently used methods for diagnosis of Legionella pneumonia lack sufficient sensitivity and 
sometimes specificity and rapidity, the detection of Legionella spp. by amplification of nucleic acids might be valuable. 
However, performing polymerase chain reaction (PCR) on clinical samples such as sputum is difficult because of the 
presence of extraneous DNA and inhibitors of the reaction. An attempt to circumvent these problems was made. 
Methods: A nested PCR method was devised using primers from the mip gene of Legionella pneumophila. This PCR 
was tested on pure cultures of legionellae and clinical isolates of other bacteria. Clinical samples (bronchoalveolar lavage 
fluid, bronchial aspirate and sputum) from patients who suffered from legionellosis and samples from patients who 
suffered from other causes of pneumonia were also tested. 
Results: The PCR was specific for L. pneurnophila and no non-Legionella bacteria reacted. Ten to 50 colony forming 
units of Legionella in the sample could be detected. Twenty-two of 25 clinical samples were positive among patients 
suffering from pneumonia proven to be due to L. pneumophila serogroups 1,3, 4, 5 and 6. Two of the three negative 
samples were from patients who had been treated with adequate therapy for at least 2 days and were culture negative. 
However, nine other culture-negative samples were PCR positive, of which seven came from patients who had been 
treated for 3-7 days. All pneumonia patients in the control group proved negative in PCR. A commercial kit for DNA 
preparation from clinical samples, based on absorption of nucleic acids to silica gel, was superior to the traditional 
phenol/chloroform extraction and increased the rapidity, simplicity and sensitivity of the procedure. 
Conclusions: A nested, simplified and rapid PCR method using rnip primers proved to be more sensitive than culture 
and as sensitive and specific as other PCR procedures previously reported. 
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INTRODUCTION 
The polymerase chain reaction (PCR) has been used 
for the detection of legionellae in water [1,2]. It has 
also been applied to clinical material, usually from the 
respiratory tract [3-81, but also serum and urine [9,10]. 
In one early study, using primer sequences of the 
macrophage infectivity potentiator (mip) gene, L. pneu- 
mophila could be detected at a level of 10-20 CFU/mL 
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in bronchoalveolar lavage (BM) fluid [3].  Mip gene 
primers were also used in two studies employing the 
commercial EnviroAmp kit (Perkin-Elmer), which was 
originally designed for detection of Legionella spp. in 
water [4,5]. Uldum studied different combinations of 
mip and 5s rRNA primers, of which some were less 
specific than others [7]. Other rnip primers were used 
for detection of kgionella DNA in serum fiom patients 
with pneumonia [9]. The 5s rRNA primers of the 
EnviroAmp kit were utilized in a study on urine 
samples from experimentally infected guinea pigs and 
fiom human patients with confirmed legionellosis [lo]. 
In two recent reports, DNA in clinical specimens was 
amplified by PCR with primers specific for the 16s 
rRNA gene of L. pneumophila [6,8]. The above men- 
tioned methods have in common that they require a 
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final hybridization step in order to aclxeve adequate 
sensitivity and spechcity. 
Another approach to PCR technology performs 
the reaction in two steps with two sets of primers in a 
so-called nested configuration. This method was 
originally applied in the detection of Mycobacterium 
leprae, Borrelia burgdorferi and herpes simplex virus 
[ll-131. The procedure increases sensitivity and speci- 
ficity in DNA-rich material, since the risk of ampli- 
fjmg non-specific sequences is decreased, and the final 
hybridization step can then be omitted. A large clinical 
vahdation of a nested system has been reported for B. 
burgdorferi [14]. The use of a nested system has been 
reported in testing one patient suffering from a L. 
pneumophila serogroup 2 infection [15]. In two other 
reports, nested primers have been evaluated for 
detection of Legionella spp. in an experimental setting 
and on samples of potable water [16,17]. 
In the present study, a nested PCR method was 
developed for the detection of L. pneumophila in 
clinical samples from patients suffering fkom proven 
legionellosis and other pneumonias. Preliminary reports 
on the principle of the method and its application to 
clinical specimens were given by the authors at the 
7th Meeting of the European Workmg Group on 
Legionella Infections (EWGLI) in Greece, May 1992, 
and at the 9th Meeting of EWGLI in Italy, June 1994. 
MATERIALS AND METHODS 
Strains 
The ATCC Legionella strains that were tested in pure 
culture are listed in Table 1. In addition to these, 12 
c h c a l  isolates consisting of L. pneumophila serogroup 
(sg) 1, six strains, L. pneumophila sg 3, one strain, L. 
pneumophila sg 5, one strain, L. pneumophila sg 6 ,  three 
strains, and L. bozemanii sg 2, one st ra in ,  were tested. 
The following non-Legionella strains (clinical isolates) 
were tested: Bacillus cereus, Bacillus sp. (not identified to 
species level), Citrobacter jieundii, Enterobacter cloacae, 
Enterococcus faecalis, Escherichia coli, Flavobacterium sp. 
group I1 b, Haemophilus influenzae, H. parainfuenzae, 
Mebsiella pneumoniae, Moraxella (Branhamella) catarrhalis, 
Mycobacterium tuberculosis, Pseudomonas aeruginosa, Staph- 
ylocoms aureus, Stenotrophomonas maltophilia, Streptococcus 
pneumoniae and Streptococcus pyogenes. The unidentified 
Bacillus sp. was isolated from a patient with Legion- 
naires’ disease (LD) during the Vaster& outbreak in 
1979 ([18] and unpublished observations). Bacilli with 
the same characteristics had also been found together 
with legionellae in the coohg  tower that caused the 
outbreak. 
L. pneumophila, Philadelphia 1 ,  sg 1 (ATCC 33152) 
was used as a control in each PCR run. Legionella strains 
were grown on BCYEa agar for 3 days at 37°C and 
suspended in ultrafiltered sterile water to a concen- 
tration of 108/mL. Non-Legionella strains were grown 
according to the requirements of each species and 
suspended in ultrafiltered sterile water to a concentra- 
tion of 108/mL. The cell concentration was measured 
by a visual count and also checked by a viability count 
in the different dilutions before preparing DNA. The 
sensitivity of the method was tested with dilutions in 
water, BAL. fluid and sputum. 
Patients 
Routine specimens h m  patients with suspected 
legionellosis were tested by culture and/or detection of 
L. pneumophila sg 1 urinary antigen. Respiratory tract 
samples from those patients who proved positive in 
Table 1 ATCC strains of Legionella tested with nested PCR 
Species Strain and serogmup (sg) PCR result 
Legionella pneumophila 
Legionella pneumophila 
Legionella pneumophila 
Legionella pneumophila 
Legionella pneumophila 
Legionella pneumophila 
Legionella pneumophila 
Legionella pneumophila 
Legionella pneumophila 
Legionella pneumophila 
Legionella mudadei 
Legionella bozemanii 
Legionella bozemanii 
Legionella longbeachae 
Legionella longbeachae 
Legionella dumofi 
Legionella gormanii 
Philadelphia 1, sg 1 
Togus 1, sg 2 
Bloomington 2, sg 3 
Los Angeles 1, sg 4 
Dallas 1, sg 1 
Chcago 2, sg 6 
Chicago 8, sg 7 
Concord 3 
Leiden 1, sg 10 
TATLOCK 
WIGA, sg 1 
Toronto 3, sg 2 
Longbeach 4, sg 1 
Tucker 1, sg 2 
W-23 
IN-23-Gl-C2, Sg 9 
LS-13 
ATCC 33152 
ATCC 33154 
ATCC 33155 
ATCC 33156 
ATCC 33216 
ATCC 33215 
ATCC 33823 
ATCC 35096 
ATCC 35289 
ATCC 43283 
ATCC 33218 
ATCC 33217 
ATCC 35545 
ATCC 33462 
ATCC 33484 
ATCC 33279 
ATCC 33297 
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either of the two tests were retested by PCR. The 
interval between initiation of adequate therapy (ery- 
thromycin and in two cases spadoxacin) and sampling 
from the respiratory tract was recorded. Samples fi-om 
23 consecutive patients who suffered from proven 
clinical pneumonia were also tested by culture, urinary 
antigen and PCR. These patients were not serologically 
tested for Legionella but were considered to suffer fi-om 
pneumonia caused by other infectious agents because 
of results from other tests. Another 10 samples con- 
sisting of BAL fluid or bronchlal aspirate were obtained 
from nine consecutive patients suffering from pneu- 
monia who had not responded to antibiotic therapy. 
These patients were tested for Legionella with the above 
methods and the indirect immunofluorescence anti- 
body test (IFAT) on serum. One culture-positive post- 
mortem sample from lung tissue that grew L. 
longbeachae sg 2 was tested by PCR. 
Culture and urinary antigen detection 
Respiratory tract specimens were cultured on BCYECX, 
MYW and BMPAcx agars [19]. Mucous specimens 
were treated with an equal volume of 10% dithlo- 
threitol (Sputolysin, Behring Diagnostics, La Jolla, 
USA). Culture was then performed on the undiluted 
specimen and on an acid-treated dilution (1:lO in 0.2 
M HCl/KCl for 5 min). The plates were incubated 
at 37°C for 10 days. Urinary antigen was detected 
with the Equate Legionella Urinary Antigen RIA kit 
(Binax, Portland, Me, USA). IFAT was performed in 
some cases at The Swedish Institute for Infectious 
Disease Control, Stockholm. 
Preparation of DNA for PCR 
Suspensions of pure bacterial cultures in ultrafiltered 
sterile water were heat lysed. Ten microliters was then 
used for PCR. BAL fluid, bronchlal aspirate and 
sputum were prepared according to two methods as 
follows without centrihgation: 
1. Two hundred and fifty microliters of sample material 
was added to an equal volume of lysis buffer (20 mM 
Tris, 100 mM KC1, 100 mM MgC12, 1% Nonidet 
P40, 1% Tween-20, pH 8.2) and 20 pL ofproteinase 
K (10 mg/mL). After incubation at 55°C for 
60-120 min and subsequent cooling, the sample was 
extracted once with 500pL of phenol/chloro- 
form/isoamyl alcohol (50:49:1) according to a 
protocol described previously [14]. Ten microliters 
of the final DNA preparation in TE buffer (10 mM 
Tris, 0.1 mM EDTA, pH 8.0), diluted l:lO, was 
used as a template in the PCR assay. 
2. The QIAamp Tissue Kit (QIAGEN, GmbH, Hilden, 
Germany) was used for rapid preparation of DNA 
from clinical specimens. This method is based on 
the principle of adsorbing nucleic acids onto a silica 
gel membrane in the presence of chaotropic salts. 
Carbohydrates, proteins and inhibitors pass through. 
The manufacturer’s instructions were followed. Two 
hundred microliters of the clinical material was 
added to the recommended amount of lysis buffer 
containing proteinase K. The nucleic acids were 
finally eluted in 100 pL of TE buffer, pH 9. Ten 
microliters of this preparation was used in the PCR. 
Primers for PCR amplification 
The assay was performed as a nested PCR. The target 
genome is the gene coding for the macrophage 
infectivity potentiator protein (mip), which has been 
mapped and which has been shown to be an important 
virulence factor in L. pneumophila [20]. The external 
primers were the same as those used by Mahubani et 
al., reported to be specific for L. pneumophila, all sero- 
groups [21], and to consist of the following sequences: 
(920-940) and 5’-GTT TTG TAT GAC TTT AAT 
TCA-3’ (1568-1548). They amplifi a 649-bp product. 
The internal primers were specially chosen for this 
study, with the sequences 5’-CAT GCA AGA CGC 
TAT GAG TG-3’ (1021-1040) and 5’-CAA GTT 
GAT CCA GCT GGC AT-3’ (1423-1392) giving rise 
to a 403-bp product. 
5’-GCT ACA GAC AAG GAT AAG TTG-3’ 
PCR amplification 
The PCR mixture (50 pL) contained 10 mM Tris, (PH 
8 4 ,  50 mM KC1, 0.1% Triton X-100, 4 mM MgCl2, 
0.2 mM of each nucleotide and 1.6 units of DNA 
polymerase (DynaZymeTM, Finnzymes OY, Espoo, 
Finland). External primers were added to a concen- 
tration of 0.12 @I and the internal primers to a 
concentration of 1.6 pM. The first step of the nested 
PCR, with the prepared DNA and the external 
primers added, was performed with 30 cycles, each 
consisting of denaturation at 95°C for 30 s (5 min in 
the first cycle), annealing at 55°C for 30 s, and 
extension at 72°C for 1 min (5 min in the last cycle). 
In order to diminish non-specific amplified products 
the reaction mixtures and prepared PCR tubes were 
kept on ice prior to loading the DNA Thermal Cycler 
(Perkin Elmer Cetus). The second step with the 
internal primers was run under the same conditions as 
the first step except that 5 pL of amplified DNA fi-om 
the first step diluted 1:lO was used as a template. Ten 
microliters of the amplified product from the second 
step was run on a 3% agarose gel, stained with ethidium 
bromide and photographed under W light. Lanes 
with a distinct band at the exact level of the positive 
control band (403 bp) were regarded as positive. 
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Each run contained a positive control prepared 
from L. pneumophila sg 1 in ultrafdtered sterile water. 
Two aliquots of every clinical sample were extracted 
and amplified. One of these was spiked with 50 cells 
of the control strain and run separately from the test 
aliquot in order to exclude false negativity because of 
inhibitors. Each run also contained a negative sputum 
sample and several blank tubes, positioned between the 
test samples and containing the PCR mix but with no 
template added, in order to detect possible contami- 
nation. To prevent cross-contamination, the different 
steps in the procedure were physically separated and the 
amplified product was handled in a hood in a separate 
room. This hood was decontaminated after each assay. 
No equipment was moved between the separate areas. 
Gowns and gloves were changed between each step in 
the procedure. 
Specificity of the amplificate 
Two amplificates, one from a known strain of L. 
pneumophilu sg 1, the other from a clinical sample in a 
patient who had grown L. pneumophila sg 6, were 
sequenced to check the specificity. The sequencing was 
performed with a Taq DyeDeoxyTM Terminator Cycle 
sequencing kit and the ABI PRISM 373 Sequencer 
(Perkin-Elmer Applied Biosystems Division, Foster 
City, Ca, USA). 
Lysates of L. pneumophila produced dstinct bands 
(Figure 1, Table 1). The other Legionella species tested 
proved negative except for a weak band produced by 
L. bozemanii sg 2 (clinical strain). The sensitivity of the 
test was in the range 10-50 CFU of Legionella in the 
sample volume from the original material, which 
corresponds to 1-5 CFU in the PCR test. The result 
was the same when legionellae were diluted in BAL 
fluid or liquefied sputum. All non-legionella bacteria 
lacked specific bands. 
Twenty-three patients were positive for Legionella 
infection by culture or L. pneumophila sg 1 urinary 
antigen assay or both (Table 2) .  PCR was performed 
on 25 specimens (four BAL fluid, 11 sputum, nine 
bronchial aspirate, and one pleural fluid) from these 
patients. Of the 25 specimens, 15 were fiom patients 
1 2 3 4 5 6 7 8 9 'I011 
4 0 3  b p +  
Figure 1 Agarose gel electrophoresis of nested PCR products. Lane 1: DNA molecular weight marker VIII 
(Boehringer Mannheim GmbH, Mannheim, Germany). Lanes 2, 4 and 6: three aliquots from the same DNA preparation of 
a sputum sample fhm a patient with Legionella infection. Lanes 3, 5, 7 and 10 are negative controls. Lane 8: a negative 
sputum. Lane 9: the same sample as in lane 8, but with 50 CFU of L. pneumophih sg 1 (ATCC 33152) added. Lane 11: 
positive control of heat-lysed L. pneumophila sg 1 (ATCC 33152). 
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Table 2 Results of PCR testing on patients with Legionella 
pneumonia in relation to previous antibiotic treatment: 25 
samples fiom 23 cases 
No. of samples 
Treatment 
Test results 52  days 3-7  day^ Total 
Culture +/ PCR + 10 2 13' 
Culture + /PCR - 1 0 1 
Culture -/PCR + 2 7 9 b  
Culture -/PCR - 1 1 2' 
Total 14 10 25' 
aNo information about therapy for one patient. 
bIncludes one bronchal aspirate overgrown by Senatia sp. and one 
pleural fluid. Both patients proved culture positive in an earlier 
sample. Seven specimens from patients with positive urinary 
antigen test. 
'Both specimens from patients with a positive urinary antigen 
test, of whom one was positive in serology (IFAT) for 
L. pneumophila sg 4. 
who suffered fi-om pneumonia caused by L. pneumo- 
phila sg 1, three by sg 3, one by sg 4, one by sg 5, and 
five by sg 6. The 14 culture-positive specimens grew L. 
pneumophila sg 1 in s i x  cases, sg 3 in three, sg 5 in one, 
and sg 6 in five. Thus, in nine patients with sg 1 
infection, diagnosis relied on a positive urinary antigen 
test. Two of these patients had been serologically tested 
but found to be negative in a serum sample from the 
acute phase. The patient with sg 4 infection showed a 
fourfold titer rise and proved weakly positive in the 
urinary antigen test but was negative in sputum culture. 
Positive bands of amplificate in clinical samples 
were distinct (Figure 1). Non-specific bands were 
always considerably weaker than the specific band. 
Non-specific bands were seen in some negative samples 
due to the presence of extraneous DNA. They did not 
interfere with the reading. The results are given in 
Table 2, including data regarding the interval between 
initiation of adequate therapy and sampling for PCR 
and culture. Notably, 7/9 culture-negative but PCR- 
positive samples were collected 3-7 days after the start 
of adequate treatment, whereas the culture positives in 
11/13 evaluable cases were sampled at an earlier stage. 
Five clinical specimens proved PCR positive when 
DNA was prepared by the QIAamp method instead of 
by phenol/chloroform extraction. The test was run 
again on three aliquots of the same DNA preparation 
fi-om each sample in three patients, who were urinary 
antigen positive but PCR negative initially. One or two 
of these aliquots from each patient then became 
positive, showing an uneven distribution of the DNA 
template in samples with few bacteria (Figure 1). 
Contamination was excluded, since blank tubes 
between the sample tubes were negative. 
Seven of the 11 culture-negative samples were 
sputum and one was pleural fluid. However, five of 
these samples and the pleural fluid were PCR positive. 
Two culture- and PCR-positive samples, one sputum 
and one bronchal aspirate, produced only two or three 
colonies on each plate, and another sputum sample that 
proved PCR negative only produced one colony of 
L. pneumophila sg 5 on each of two plates. Ten of 14 
culture-positive specimens were BAL fluid or bronchial 
aspirate. 
The 33 samples from pneumonia patients who 
were negative on Legionella testing (in 10 cases in- 
cluding serology) proved negative in PCR. The post- 
mortem sample from lung tissue that grew L. long- 
beachae sg 2 showed no bands in PCR. 
Sequencing 250 bp of the amplificate showed fhll 
agreement with the sequence published previously 
[18], except for 1 bp. 
DISCUSSION 
Methods used presently for diagnosis of Legionella 
infection lack sufficient sensitivity and sometimes also 
specificity [22]. Culture is the most specific method, 
but sensitivity is variable. Serology is not of value in 
the acute phase of disease and the serologic methods 
have not been satisfactorily validated in the diagnosis of 
non-L. pneumophila sg 1 infections. Direct immuno- 
fluorescence @FA) of specimens from the respiratory 
tract using monoclonal fluorescein isothiocyanate 
(F1TC)-conjugated antibody is specific but insensitive 
and needs much experience to read. Detection of 
Legionella antigen in urine using enzyme immunoassay 
(EIA) or radioimmunoassay (RIA) is very specific, but 
the commCrcial systems only detect L. pneumophila sg 
1 infections. Therefore, there is a need for other rapid 
and specific methods that are more sensitive than those 
now used. 
Methods for amplification of DNA and RNA have 
become important in diagnosing infections caused by 
slow-growing and fastidious organisms. Such methods 
are very sensitive (in theory detecting one bacterial cell) 
and also very specific. However, they are still too labor- 
intensive to be practical in clinical use. This may be due 
to the complicated extraction methods used or to the 
need for hybridization with a probe in the final step of 
the test. We used a simplified extraction procedure, 
which improved the results of testing, and we also used 
a nested system for amplification, which effectively 
removes the need for hybridization. 
A nested PCR method in our setting can detect 
10-50 Legionella CFU in the original sample, and 
simdar numbers when bacterial cells are added to BAL 
fluid or sputum. This should be quite adequate unless 
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the method is hampered by problems in processing 
clinical specimens or by inhibitors in them. Positive 
bands were easy to read. Though negative lanes in the 
ethidium bromide-stained gel would sometimes show 
non-specific bands, this did not constitute a problem. 
The preparation of DNA &om clinical specimens with 
the rapid QIAamp method increased sensitivity and 
rapidity. The specificity of the amplified product could 
be confirmed by sequencing two amplificates &om 
dfferent serogroups. Therefore, we do not believe that 
a final hybridization with an internal probe is needed. 
No false-positive results were obtained with either the 
clinical specimens or the cultured non-L. pneumophila 
strains. Though the use of a nested system theoretically 
might increase the risk of cross-contamination, this was 
not seen. Thus, our precautions, described above, were 
sufficient. 
Because legionellosis is relatively rare, it was not 
found feasible to study samples from patients with 
the suspected illness consecutively. It is therefore not 
possible to calculate sensitivity in the usual terms. 
However, all culture-positive specimens, mostly sampled 
in an early phase of disease, were also positive in PCR, 
except for one culture that only grew one legionella 
colony on each of two plates. We have not been able 
to establish any reason for the negative PCR in this 
latter case. However, the result may be an incidental 
effect of random distribution in samples containing 
very few Legionella cells. This is substantiated by the 
fact that different aliquots of the same DNA pre- 
paration fiom culture-negative specimens could vary in 
positivity. It might therefore be prudent to perform 
PCR on more than one aliquot &om each sample 
preparation. Seven of nine samples firom patients who 
were urinary antigen positive, but culture negative, 
proved positive in PCR. Of the total nine culture- 
negative and PCR-positive samples, seven were from 
patients who had been treated adequately with erythro- 
mycin or sparfloxacin for 3-7 days. Ths seems to be 
an important advantage of the PCR technique. There- 
fore, the sensitivity of our PCR on respiratory tract 
samples is probably very high. 
Since the control group of patients suffering fkom 
other causes of pneumonia was completely negative in 
PCR, specificity should be adequate. Not all of these 
had been serologically tested for Legionella, but they 
were clinically judged to suffer fiom other kinds of 
pneumonia. Positive urinary antigen tests per se have 
generally only been regarded as indicative of a pre- 
sumptive diagnosis of legionellosis, but objections to 
this view have been expressed [23]. Though cross- 
reactions might occur with other Legionella serogroups, 
as in the sg 4 infection mentioned above, specificity is 
close to 1 .O in cases of clinical pneumonia. The positive 
urinary antigen tests in our samples were well above 
cut-off values. 
Several amplification methods have now been 
reported. Those relying on the 5s rRNA gene seem to 
have problems with specificity in clinical specimens 
[7,10]. However, the primers used cover a broader 
spectrum of Legionella spp. Primer sequences from the 
mip gene are in some instances only specific for L. 
pneumophila, and in others seem to cover a broader 
range of species [3,7]. Mip genes are also found in other 
Legionella spp. The external primers that we used are 
principally specific for L. pneumophila, though we 
observed a weak reaction with a L. bozemanii strain. 
This narrow specificity might be a disadvantage but still 
covers approximately 90% of Legionella infections [22]. 
The sensitivity of our method on diluted specimens 
was the same irrespective of the diluent used (distilled 
water, BAL fluid or sputum). The QIAamp Tissue Kit 
seemed to remove the inhibitors fiom the c h c a l  
samples. Recently, the use of primers fiom 16s rRNA 
gene has been reported [6,8]. These PCRs have been 
run in trahtional fashon, hybridzing the final product 
with a probe.They have shown the same level of 
sensitivity as ours but cover a broader range of Legionella 
spp. Our method has been run as a nested system. A 
nested system using different rnip primers fiom ours has 
been reported, but in t h s  case only one patient with a 
L. pneumophila sg 2 pneumonia was tested [15]. We 
believe that combining the use of mip primers with 
the use of a nested PCR may be advantageous in 
constructing a rapid amplification test for clinical 
samples without loss of specificity and sensitivity. 
In summary, we have designed a nested PCR 
which is as sensitive and as specific as those previously 
described without needing a final hybridization step. 
Full sensitivity demands an efficient preparation of 
DNA fiom clinical samples in order to deprive the 
material of inhibitors to the reaction. This can be done 
with a commercially available kit, adsorbing DNA onto 
silicate gel. Further prospective studies on consecutively 
studied patients with atypical pneumonia are needed 
for fill evaluation. 
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